These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21104925)

  • 1. HIV protease inhibitors: garlic supplements and first-pass intestinal metabolism impact on the therapeutic efficacy.
    Berginc K; Trdan T; Trontelj J; Kristl A
    Biopharm Drug Dispos; 2010 Nov; 31(8-9):495-505. PubMed ID: 21104925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of aged garlic extract on the uptake of saquinavir and darunavir into HepG2 cells and rat liver slices.
    Berginc K; Trontelj J; Kristl A
    Drug Metab Pharmacokinet; 2010; 25(3):307-13. PubMed ID: 20610890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Garlic flavonoids and organosulfur compounds: impact on the hepatic pharmacokinetics of saquinavir and darunavir.
    Berginc K; Milisav I; Kristl A
    Drug Metab Pharmacokinet; 2010; 25(6):521-30. PubMed ID: 20930421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanisms responsible for garlic - drug interactions and their in vivo relevance.
    Berginc K; Kristl A
    Curr Drug Metab; 2013 Jan; 14(1):90-101. PubMed ID: 21838705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers.
    Alsenz J; Steffen H; Alex R
    Pharm Res; 1998 Mar; 15(3):423-8. PubMed ID: 9563072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transwell-grown HepG2 cell monolayers as in vitro permeability model to study drug-drug or drug-food interactions.
    Berginc K; Kristl A
    J Med Food; 2011; 14(1-2):135-9. PubMed ID: 21138349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Mathematical simulation to explain the coordinated functions of efflux and metabolism limiting the transport of anti-HIV agents across Caco-2 cells.
    Patel J; Hussain A; Pal D; Mitra AK
    Am J Ther; 2004; 11(2):114-23. PubMed ID: 14999363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells.
    Washington CB; Duran GE; Man MC; Sikic BI; Blaschke TF
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):203-9. PubMed ID: 9803961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components.
    Eagling VA; Profit L; Back DJ
    Br J Clin Pharmacol; 1999 Oct; 48(4):543-52. PubMed ID: 10583025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of pharmacokinetic enhancement between ritonavir and saquinavir; micro/small dosing tests using midazolam (CYP3A4), fexofenadine (p-glycoprotein), and pravastatin (OATP1B1) as probe drugs.
    Ieiri I; Tsunemitsu S; Maeda K; Ando Y; Izumi N; Kimura M; Yamane N; Okuzono T; Morishita M; Kotani N; Kanda E; Deguchi M; Matsuguma K; Matsuki S; Hirota T; Irie S; Kusuhara H; Sugiyama Y
    J Clin Pharmacol; 2013 Jun; 53(6):654-61. PubMed ID: 23381882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity.
    Patel J; Buddha B; Dey S; Pal D; Mitra AK
    Am J Ther; 2004; 11(4):262-77. PubMed ID: 15266218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
    Profit L; Eagling VA; Back DJ
    AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro interactions between aged garlic extract and drugs used for the treatment of cardiovascular and diabetic patients.
    Berginc K; Žakelj S; Kristl A
    Eur J Nutr; 2010 Sep; 49(6):373-84. PubMed ID: 20140680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boosting of HIV protease inhibitors by ritonavir in the intestine: the relative role of cytochrome P450 and P-glycoprotein inhibition based on Caco-2 monolayers versus in situ intestinal perfusion in mice.
    Holmstock N; Annaert P; Augustijns P
    Drug Metab Dispos; 2012 Aug; 40(8):1473-7. PubMed ID: 22550269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of saquinavir/ritonavir on P-glycoprotein activity in healthy volunteers using digoxin as a probe.
    Schmitt C; Kaeser B; Riek M; Bech N; Kreuzer C
    Int J Clin Pharmacol Ther; 2010 Mar; 48(3):192-9. PubMed ID: 20197013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HIV and Anti-Hepatitis C Virus Drugs Inhibit P-Glycoprotein Efflux Activity in Caco-2 Cells and Precision-Cut Rat and Human Intestinal Slices.
    Martinec O; Huliciak M; Staud F; Cecka F; Vokral I; Cerveny L
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
    Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
    Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of HIV protease inhibitors with ATP-dependent drug export proteins.
    Gutmann H; Fricker G; Drewe J; Toeroek M; Miller DS
    Mol Pharmacol; 1999 Aug; 56(2):383-9. PubMed ID: 10419558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance?
    Jones K; Bray PG; Khoo SH; Davey RA; Meaden ER; Ward SA; Back DJ
    AIDS; 2001 Jul; 15(11):1353-8. PubMed ID: 11504956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism.
    Fitzsimmons ME; Collins JM
    Drug Metab Dispos; 1997 Feb; 25(2):256-66. PubMed ID: 9029057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.